e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Cystic fibrosis: genes, inflammation and more
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased EMMPRIN and MT1-MMP levels in the plasma of the stable adult patients with cystic fibrosis
S. Jouneau, G. Leveiller, B. Desrues, V. Lagente, C. Martin-Chouly (Rennes, France)
Source:
Annual Congress 2005 - Cystic fibrosis: genes, inflammation and more
Session:
Cystic fibrosis: genes, inflammation and more
Session type:
Thematic Poster Session
Number:
2579
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Jouneau, G. Leveiller, B. Desrues, V. Lagente, C. Martin-Chouly (Rennes, France). Increased EMMPRIN and MT1-MMP levels in the plasma of the stable adult patients with cystic fibrosis. Eur Respir J 2005; 26: Suppl. 49, 2579
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
KL-6 serum levels in adult cystic fibrosis patients
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011
Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients
Source: Eur Respir J 2014; 44: 802-805
Year: 2014
Increased expression of MMP-2 in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 361s
Year: 2005
Serum levels of TIMP-1 and TIMP-2 are elevated in patients with pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003
Are there serum levels of MMP-2 and MMP-9 may be markers of COPD phenotypes?
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Increased concentration of matrix metalloproteinase-9 in serum of COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005
Sputum and plasma adiponectin levels in clinically stable adult cystic fibrosis patients with CFTR I1234V mutation
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Progression of monocrotaline-induced pulmonary hypertension in rats can be monitored by plasma activity of matrix metalloproteinase-2 and plasma levels of tenascin-C and proBNP
Source: Eur Respir J 2007; 30: Suppl. 51, 7s
Year: 2007
Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis
Source: Eur Respir J 2015; 46: 384-394
Year: 2015
Altered expression of adhesion molecules in circulating neutrophils of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 479s
Year: 2002
Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011
Increased intraalveolar level of soluble endothelial protein C receptor in patients with interstitial lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 319s
Year: 2004
Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Relation of serum IGF-1 and IGFBP3 levels with acute exacerbation in cystic fibrosis
Source: International Congress 2018 – Clinical problems in paediatric pulmonology
Year: 2018
Circulating matrix metalloproteinase-9 (MMP-9) is associated with the extension of lung disease in patients with active tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 35s
Year: 2004
Increased polysialylation in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
MMP expression and abnormal lung permeability are important determinants of outcome in IPF
Source: Eur Respir J 2009; 33: 77-84
Year: 2009
Serum lipid concentrations and malnutrition in adult cystic fibrosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 58s
Year: 2006
Decreased levels of secretory leucoprotease inhibitor in the
pseudomonas
-infected cystic fibrosis lung are due to neutrophil elastase degradation
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept